Product Information
OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET is a generic product labeled by Elite Laboratories, Inc., priced at $0.2308 per EA under NDC 64850062301. Its NADAC has been published 65 times since Jul 9, 2025.
FDA first approved this application on Jul 2, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 10 mg/1; mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850062301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209385FDA Approved
7/2/2018
TE Code
AA
On Market Since
12/4/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has been published 65 times since Jul 9, 2025, and over the history we have for it it has declined 15.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2308 per EA |
|---|---|
| All-time high | $0.2716 (Jul 16, 2025) |
| All-time low | $0.2292 (May 20, 2026) |
| 52-week high | $0.2472 |
| 52-week low | $0.2292 |
| Median price | $0.2406 |
| Average price | $0.2419 |
| Largest weekly change | -4.3% (Aug 20, 2025) |
| Weeks tracked | 65 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Oxycodone Hydrochloride and Acetaminophen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Elite Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxycodone Hydrochloride and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET, manufactured by Elite Laboratories, Inc., is $0.2308 per EA (NDC 64850062301), effective Sep 30, 2026.
How has the price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has declined 15.0%. It has been tracked across 65 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
Since Jul 9, 2025, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has ranged from a low of $0.2292 (May 20, 2026) to a high of $0.2716 (Jul 16, 2025), with a median of $0.2406 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET (NDC 64850062301) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.